Supporting this observation, TGFB2–Smad3 pathway has been demonstrated to promote proliferation and epithelial–mesenchymal transition in several cancers, recently also in bladder cancer [14, 15]. The gene discussed is SMAD3; the disease is urinary bladder cancer.